D
DelRicht Research | Neighborhood Health - Prairieville, LA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
NRCT-101SR
X0002
STS101
Galcanezumab
EVO100
Tolperisone
Parent organization
This site is a part of DelRicht Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 8 total trials
The purpose of this study is to evaluate the effectiveness of CD388 in preventing symptomatic laboratory-confirmed influenza infections, as compared...
Active, not recruiting
Influenza
Combination Product: CD388 Injection
Combination Product: Placebo
To evaluate the efficacy and safety of NRCT-101SR compared to placebo in subjects 13-17 years of age with ADHD
Enrolling
Attention-Deficit/Hyperactivity Disorder (ADHD)
Drug: NRCT-101SR
Trial sponsors
C
E
N
N
S
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems